Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota

BackgroundMinimal hepatic encephalopathy (MHE) is an early stage in the pathogenesis of hepatic encephalopathy. Intestinal microbiota is involved in the pathogenesis of hepatic encephalopathy and has become an important therapeutic target. Since there is no unified treatment principle for MHE, this...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ming-Wei Wang, Wei-Juan Ma, Yan Wang, Xiao-Han Ma, Yu-Feng Xue, Jing Guan, Xi Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2023-03-01
Colecção:	Frontiers in Microbiology
Assuntos:	probiotics rifaximin lactulose minimal hepatic encephalopathy gut microbiota
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1091167/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!